These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18556452)

  • 21. Discordant response to rituximab in a systemic sclerosis patient with associated myositis.
    Fabri M; Hunzelmann N; Krieg T; Rubbert A
    J Am Acad Dermatol; 2008 May; 58(5 Suppl 1):S127-8. PubMed ID: 18489049
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.
    Hairston BR; Davis MD; Gibson LE; Drage LA
    Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383
    [No Abstract]   [Full Text] [Related]  

  • 23. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.
    Carella AM; D'Arena G; Greco MM; Nobile M; Cascavilla N
    Bone Marrow Transplant; 2008 Jun; 41(12):1063-5. PubMed ID: 18317457
    [No Abstract]   [Full Text] [Related]  

  • 25. Comment on: a case of Raynaud's phenomenon in mixed connective tissue disease responding to Rituximab therapy response.
    Dunkley L; Green M; Gough A
    Rheumatology (Oxford); 2007 Oct; 46(10):1628-9. PubMed ID: 17766999
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of rituximab in Felty's syndrome.
    Lekharaju V; Chattopadhyay C
    Ann Rheum Dis; 2008 Sep; 67(9):1352. PubMed ID: 18697782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 28. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
    Browning CE; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
    Blank N; Max R; Schiller M; Briem S; Lorenz HM
    Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
    [No Abstract]   [Full Text] [Related]  

  • 30. Rituximab for treatment of scleritis associated with rheumatoid arthritis.
    Chauhan S; Kamal A; Thompson RN; Estrach C; Moots RJ
    Br J Ophthalmol; 2009 Jul; 93(7):984-5. PubMed ID: 19553514
    [No Abstract]   [Full Text] [Related]  

  • 31. Case series of recalcitrant livedoid vasculopathy treated with rivaroxaban.
    Lee JM; Kim IH
    Clin Exp Dermatol; 2016 Jul; 41(5):559-61. PubMed ID: 26993107
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective treatment of refractory pulmonary hemorrhage with monoclonal anti-CD20 antibody (rituximab).
    Pinto LF; Candia L; Garcia P; Marín JI; Pachón I; Espinoza LR; Marquez J
    Respiration; 2009; 78(1):106-9. PubMed ID: 18799870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab treatment in children: comment on the review by Looney et al.
    Bader-Meunier B
    Arthritis Rheum; 2008 Aug; 58(8):2583; author reply 2583-4. PubMed ID: 18668567
    [No Abstract]   [Full Text] [Related]  

  • 35. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of efficacy of rituximab in Felty's syndrome.
    Sordet C; Gottenberg JE; Hellmich B; Kieffer P; Mariette X; Sibilia J
    Ann Rheum Dis; 2005 Feb; 64(2):332-3. PubMed ID: 15647445
    [No Abstract]   [Full Text] [Related]  

  • 37. Monozygotic twins with stiff person syndrome and autoimmune thyroiditis: rituximab inefficacy in a double-blind, randomised, placebo controlled crossover study.
    Venhoff N; Rizzi M; Salzer U; Bossaller L; Thoden J; Eibel H; Walker UA
    Ann Rheum Dis; 2009 Sep; 68(9):1506-8. PubMed ID: 19674986
    [No Abstract]   [Full Text] [Related]  

  • 38. Livedoid vasculopathy - a challenging disease.
    Vieira R; Bernardes JM; Pinto JA; Costa L
    Acta Reumatol Port; 2016; 41(3):273-274. PubMed ID: 27155327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the off-label usage of rituximab in a large teaching hospital in New South Wales.
    Lowinger JS; Kaye KI
    Intern Med J; 2008 Feb; 38(2):146-8. PubMed ID: 18290836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.